Published in Lancet on January 01, 1979
Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest (1981) 1.63
Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Proc Natl Acad Sci U S A (1979) 1.44
Epstein-Barr virus infection and autoimmunity in rheumatoid arthritis. Ann Rheum Dis (1988) 1.03
Antibodies to EB virus- and cytomegalovirus-induced antigens in early rheumatoid disease. Clin Exp Immunol (1982) 0.91
Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen 1. Ann Rheum Dis (1988) 0.90
A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis. Arthritis Res Ther (2012) 0.80
Spontaneous cytotoxicity of rheumatoid and normal peripheral blood mononuclear cells against 4 human lymphoblastoid cell lines. Ann Rheum Dis (1980) 0.79
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum (1994) 14.16
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum (2013) 11.18
Long-term cognitive impairment after critical illness. N Engl J Med (2013) 9.20
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer (1989) 8.07
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med (2001) 7.07
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM (1994) 5.23
Structural polarity and directional growth of microtubules of Chlamydomonas flagella. J Mol Biol (1974) 4.80
Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst (1966) 4.19
Microtubule assembly in vitro. Fed Proc (1974) 3.82
Quantitation of thermography in arthritis using multi-isothermal analysis. I. The thermographic index. Ann Rheum Dis (1974) 3.82
Human parvovirus arthropathy. Lancet (1985) 3.76
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst (1971) 3.30
A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell (1995) 3.17
Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. J Virol (1980) 3.00
Metastatic pneumococcal endophthalmitis: report of two cases and review of literature. J Infect (1990) 2.98
The maximum oxygen intake. An international reference standard of cardiorespiratory fitness. Bull World Health Organ (1968) 2.87
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) (1981) 2.84
The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum (1995) 2.82
Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Res (1981) 2.74
Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med (1997) 2.73
First-trimester diagnosis and management of pregnancies implanted into the lower uterine segment Cesarean section scar. Ultrasound Obstet Gynecol (2003) 2.62
Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity. Int J Cancer (1982) 2.55
Studies with Burkitt's lymphoma. Wistar Inst Symp Monogr (1965) 2.51
Efficacy of tests used to monitor rheumatoid arthritis. Lancet (1989) 2.50
Joint hypermobility leading to osteoarthrosis and chondrocalcinosis. Ann Rheum Dis (1978) 2.44
The importance of iron in rheumatoid disease. Lancet (1981) 2.44
Focal therapy for localized prostate cancer: a phase I/II trial. J Urol (2011) 2.43
Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res (1998) 2.33
Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum (1997) 2.31
No to BDA. Br Dent J (2010) 2.31
Host genetic factors influence disease progression in chronic hepatitis C. Hepatology (2000) 2.26
Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis. Br Med J (1975) 2.24
A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer (1985) 2.23
Paranoid Psychosis Successfully Treated by Adrenalectomy. Br Med J (1945) 2.23
Microtuble assembly: some possible regulatory mechanisms. J Supramol Struct (1974) 2.21
Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA (2001) 2.16
Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol (1993) 2.15
Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation (1990) 2.13
Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol (1999) 2.12
Targeted testicular excision biopsy: when and how should we try to avoid radical orchidectomy? Clin Radiol (2009) 2.11
Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J Gen Virol (1989) 2.10
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med (1988) 2.09
Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev (2006) 2.03
Production of lymphokine mRNA by CD45R+ and CD45R- helper T cells from human peripheral blood and by human CD4+ T cell clones. J Immunol (1989) 2.03
T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. Cell Immunol (1984) 2.01
Effect of pregnancy on the isoantibody response in rabbits. Nature (1971) 1.91
HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells. Nature (1980) 1.90
Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study. Q J Med (1976) 1.90
Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet (2001) 1.89
Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest (1997) 1.89
Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med (1984) 1.88
Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis (1984) 1.86
Intra-articular steroids in osteoarthritis. Rheumatol Rehabil (1980) 1.85
Proposed standards for professional health sciences library services in hospitals of New York State. Bull Med Libr Assoc (1981) 1.85
Sharing care: the psychiatrist in the family physician's office. Can J Psychiatry (1997) 1.85
Mechanisms of GDF-5 action during skeletal development. Development (1999) 1.83
The p150,95 molecule is a marker of human mononuclear phagocytes: comparison with expression of class II molecules. Eur J Immunol (1986) 1.82
A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A (1995) 1.82
Classical versus non-renal Wegener's granulomatosis. Q J Med (1994) 1.79
High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series. Br J Cancer (2009) 1.78
Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation (2001) 1.78
Hepatitis-B antibody in polymyalgia Rheumatica. Lancet (1975) 1.77
Naturally occurring anti-tissue antibodies in rat sera. Clin Exp Immunol (1966) 1.75
Various forms of Epstein-Barr virus infection in man: established facts and a general concept. Lancet (1973) 1.73
Plasmapheresis in the management of acute systemic lupus erythematosus? Lancet (1976) 1.73
Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis. BMJ (1992) 1.72
Control of calcium oscillations by membrane fluxes. Proc Natl Acad Sci U S A (2004) 1.72
Pathogenesis of infectious mononucleosis. Lancet (1977) 1.70
The long-term effects of treating rheumatoid arthritis. J R Coll Physicians Lond (1983) 1.70
Hypothalamo-pituitary-adrenal function in patients on long-term adrenocorticotrophin therapy. Ann Rheum Dis (1968) 1.68
The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol (1994) 1.67
In vitro responses to a 65-kilodalton mycobacterial protein by synovial T cells from inflammatory arthritis patients. J Immunol (1989) 1.67
Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases. Ann Rheum Dis (1984) 1.66
IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol (1981) 1.66
Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature (1985) 1.64
Autoimmune haemolytic anaemia and mefenamic acid therapy. Br Med J (1968) 1.62
Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma. Int J Cancer (1985) 1.62
Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas. Int J Cancer (1979) 1.62
Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol (1995) 1.61
The spv genes on the Salmonella dublin virulence plasmid are required for severe enteritis and systemic infection in the natural host. Infect Immun (1997) 1.61
A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study. Contemp Clin Trials (2013) 1.61
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60
Blastomycosis in six dogs in New York state. J Am Vet Med Assoc (1997) 1.60
Sulphasalazine in psoriatic arthritis: a double-blind placebo-controlled study. Br J Rheumatol (1990) 1.57
Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J Exp Med (1990) 1.57
In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients. Int J Cancer (1985) 1.55
Factor VIII related antigen in connective tissue disease patients and relatives. Br J Rheumatol (1990) 1.55
Specific immunofluorescence test for the herpes-type EB virus of Burkitt lymphoblasts, authenticated by electron microscopy. J Natl Cancer Inst (1968) 1.54
Postprandial bloating after laparoscopic Nissen fundoplication. Can J Surg (2001) 1.53
Vitamin D deficiency, spontaneous fractures, and osteopenia in rheumatoid arthritis. Br Med J (1974) 1.53
Cesarean scar pregnancy. Ultrasound Obstet Gynecol (2003) 1.53